Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,134
-$17,029 QoQ
Shares Held
20
-84.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,577
of 1,603 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLLENCREST CAPITAL MANAGEMENT holds $5,976,653 across 13 Drug Manufacturers - General names. NVS ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,074 | $1,475,276 | |
| 2 | ABBV |
AbbVie Inc.
|
5,785 | $1,455,737 | |
| 3 | JNJ |
Johnson & Johnson
|
4,993 | $1,268,072 | |
| 4 | LLY |
ELI LILLY & Co
|
768 | $921,162 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,878 | $626,823 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
744 | $93,996 | |
| 7 | NVO |
Novo Nordisk A S
|
1,841 | $88,257 | |
| 8 | PFE |
Pfizer Inc
|
881 | $21,214 |
All Filings in NVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,134 | 20 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $20,163 | 132 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $18,198 | 132 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $29,751 | 232 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $28,074 | 232 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $25,863 | 232 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $22,575 | 232 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $26,684 | 232 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $24,698 | 232 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $22,441 | 232 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $23,425 | 232 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,631 | 232 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $23,411 | 232 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $21,344 | 232 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $21,047 | 232 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||